The chairman of global biotechnology giant CSL, Brian McNamee, has warned that Melbourne's lockdown will have "devastating" economic, social and health costs and called for governments to put forward a credible virus strategy that is "not seen as blunt or punitive to the wider society".
The Melbourne-based medical doctor and chairman of Australia's second most valuable company, which is working to develop a COVID-19 vaccine, Dr McNamee said elimination of the virus in Victoria "seems remarkably ambitious from where we are now".
Loading...
John Kehoe is economics editor at Parliament House, Canberra. He writes on economics, politics and business. John was Washington correspondent covering Donald Trump’s first election. He joined the Financial Review in 2008 from Treasury. Connect with John on Twitter. Email John at jkehoe@afr.com
